foscarnet and letermovir

foscarnet has been researched along with letermovir in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Meesing, A; Razonable, RR1
Sinkó, J1
Müller, TF; Näf, B; Rho, E; Schachter, T; von Moos, S; Wüthrich, RP1

Reviews

2 review(s) available for foscarnet and letermovir

ArticleYear
New Developments in the Management of Cytomegalovirus Infection After Transplantation.
    Drugs, 2018, Volume: 78, Issue:11

    Topics: Acetates; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Organ Transplantation; Quinazolines; Valganciclovir

2018
[Current treatment modalities of immunocompromised patients with cytomegalovirus infection. II. Therapeutic options and management strategies].
    Orvosi hetilap, 2019, Volume: 160, Issue:10

    Topics: Acetates; Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Quinazolines; Stem Cell Transplantation

2019

Other Studies

1 other study(ies) available for foscarnet and letermovir

ArticleYear
Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
    Clinical transplantation, 2021, Volume: 35, Issue:11

    Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir

2021